AgriLabs Buys Into Vaccine Manufacturing

AgriLabs LLC has acquired the manufacturing operations of Antelope Valley Bios Inc., Benchmark Biolabs Inc. and Benchmark’s ownership interest in VaxLiant.

AgriLabs LLC has entered the vaccine business by acquiring the manufacturing operations of Antelope Valley Bios Inc., Benchmark Biolabs Inc. and Benchmark’s ownership interest in VaxLiant, all based in Lincoln, Neb. 

The deals, announced April 27, make AgriLabs a provider of “concept-to-commercialization services for vaccines” administered to pigs, cattle and poultry, the company reported. 

“By adding state-of-the-art manufacturing capabilities to our U.S. marketing and sales operations, we can deliver more value to veterinarians and producers, both domestically and worldwide,” said AgriLabs’ CEO, Steve Schram. 

The company is based in St. Joseph, Mo. 

AgriLabs’ subsidiaries will continue to operate as standalone business entities, the company added.


Originally published in the June 2016 issue of Veterinary Practice News. Did you enjoy this article? Then subscribe today! 

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.